Advancement in the pharmacogenetics of antiplatelet drugs / 中国药理学通报

ABSTRACT

Nowadays,cerebrovascular disease is one of the main causes of human death.Activation and aggregation of the platelet play core roles in the development of cerebrovascular diseases.A lot of clinical applications have showed that there are great interindividual differences in the response to antiplatelet drugs,and many patients have developed drug resistances.Pharmacogenetic studies have revealed that genetics is one of the key factors resulting in the interindividual differences of the response to antiplatelet drugs.In this overview,the newest advancement in pharmacogenetics is summarized with respect to the antiplatelet drugs.